Stockscreener 앱 받기
7.00
1.06%
-0.075
시장 영업 전:
7.00
전일 마감가:
$7.075
열려 있는:
$6.98
하루 거래량:
2,931
Relative Volume:
0.17
시가총액:
$19.45M
수익:
$22.03M
순이익/손실:
$-19.91M
주가수익비율:
-0.3781
EPS:
-18.5137
순현금흐름:
$-16.84M
1주 성능:
-1.27%
1개월 성능:
+2.04%
6개월 성능:
+5.11%
1년 성능:
-58.03%
1일 변동 폭
$6.9375
$7.00
1주일 범위
$6.70
$7.4699
52주 변동 폭
$4.14
$17.76
Lifeward Ltd Stock (LFWD) Company Profile
명칭
Lifeward Ltd
전화
15082511154
주소
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
7.00 | 19.45M | 22.03M | -19.91M | -16.84M | -18.51 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-10 | 개시 | Laidlaw | Buy |
| 2017-04-03 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2016-12-16 | 개시 | Oppenheimer | Outperform |
| 2016-07-15 | 개시 | Piper Jaffray | Overweight |
| 2015-05-22 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | 재확인 | Barclays | Equal Weight |
| 2014-10-07 | 개시 | Barclays | Equal Weight |
모두보기
Lifeward Ltd 주식(LFWD)의 최신 뉴스
Study of Lifeward exoskeleton found zero fractures in 97 Germany users - Stock Titan
Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton - Yahoo Finance Singapore
Working capital per share of Lifeward Ltd. – MUN:2RW - TradingView
Lifeward (LFWD) price target increased by 344.44% to 20.40 - MSN
7.26M Lifeward shares registered for resale by selling holders (NASDAQ: LFWD) - Stock Titan
Lifeward stock plummets on pricing of $2.6M public offering - MSN
Jeannine Lynch to Exit Lifeward as VP of Strategy and Market Access - TradingView
Lifeward (NASDAQ: LFWD) to end VP Strategy role May 3 - Stock Titan
Moshe H Rozenbaum Net Worth (2026) - GuruFocus
William Mark Sigsbee Net Worth (2026) - GuruFocus
Lifeward (LFWD) director receives 11,485 RSUs vesting over four quarters - Stock Titan
Lifeward Ltd. (LFWD) director submits Form 3 with no insider trades - Stock Titan
Lifeward (LFWD) awards 11,485 RSUs to company director - Stock Titan
Lifeward (LFWD) director Moshe H Rozenbaum files initial Form 3 - Stock Titan
Returns Recap: Can Lifeward Ltd be recession proofPortfolio Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Recap Report: Is Lifeward Ltd a turnaround storyWeekly Trade Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug PreEarnings: Is Lifeward Ltd a good stock for dollar cost averaging2026 Reactions & Reliable Volume Spike Alerts - baoquankhu1.vn
Aug Setups: Why is Lifeward Ltd stock going upMarket Trend Report & High Accuracy Trade Alerts - baoquankhu1.vn
Lifeward scoops US$20M after completing Oratech Pharma takeover - Mugglehead Investment Magazine
Sell Signal: Does Lifeward Ltd offer margin of safety2026 Risk Factors & Technical Buy Zone Confirmation - baoquankhu1.vn
Big Picture: Will Lifeward Ltd benefit from government policyForecast Cut & Advanced Technical Signal Analysis - baoquankhu1.vn
S P Trends: Is Lifeward Ltd stock heavily shorted2026 Update & Safe Capital Investment Plans - baoquankhu1.vn
LFWD Earnings History & Surprises | EPS & Revenue Results | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
Oramed Completes Oratech Sale and Strategic Lifeward Financing - The Globe and Mail
Lifeward Restores Nasdaq Compliance With Audit Committee Changes - The Globe and Mail
Lifeward Ltd. 8-K SEC Filing March 2026: Company Information, NASDAQ Listing, and Entity Details - Minichart
Oramed (ORMP) completes Oratech sale and buys $9M Lifeward notes - Stock Titan
Lifeward regains Nasdaq compliance after audit committee appointments By Investing.com - Investing.com South Africa
Lifeward regains Nasdaq compliance after audit committee appointments - investing.com
Lifeward regains Nasdaq audit committee compliance after new appointments - TradingView
Lifeward (NASDAQ: LFWD) regains Nasdaq audit committee compliance after board change - Stock Titan
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Dow Update: Will Lifeward Ltd outperform small cap indexesMarket Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares - stocktitan.net
Lifeward (LFWD) CEO awarded 172,698 options at $6.53 strike - Stock Titan
Director at Lifeward (LFWD) granted 7,657 RSUs vesting quarterly - stocktitan.net
Lifeward (LFWD) director receives 7,657 RSU grant under 2025 plan - stocktitan.net
Director Miriam Kidron receives 7,657-share RSU grant at Lifeward (NASDAQ: LFWD) - Stock Titan
Lifeward (LFWD) director Reznick Yehuda files initial insider Form 3 - Stock Titan
Lifeward (LFWD) director Nadav Kidron submits initial Form 3 ownership - stocktitan.net
Lifeward (LFWD) director Miriam Kidron submits initial Form 3 insider report - stocktitan.net
Oramed (NASDAQ: ORMP) pivots with Lifeward deal and Alpha Tau stake - Stock Titan
Lifeward Completes Oratech Acquisition and Secures Private Financing - The Globe and Mail
Lifeward (LFWD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga France
Aug Spikes: Is Lifeward Ltd in a long term uptrend2026 Levels & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Lifeward closes Oramed partnership, secures $10 million funding By Investing.com - Investing.com Australia
Lifeward Ltd. 8-K Filing: Share Purchase Agreement Assignment to Oratech Ltd. and Entity Information (March 2026) - Minichart
Lifeward Closes Oramed Partnership, Acquires Oratech Pharma - Moomoo
Lifeward closes Oramed partnership, secures $10 million funding - Investing.com
Lifeward Ltd (LFWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.93%
자본화:
|
볼륨(24시간):